Literature DB >> 7384844

Meige's syndrome.

T Ashizawa, B M Patten, J Jankovic.   

Abstract

We present two women with Meige's syndrome, a condition in which the clinical presentation differs from tardive dyskinesia by the lack of exposure to neuroleptic drgus, greater severity of blepharospasms, and more prolonged dystonic contractions of oromandibular muscles. In this condition we used triaxial accelerometry to detect dystonia, which may also appear in limb and respiratory muscles. Although psychologic factors may affect the symptoms, the basic pathogenesis of this syndrome does not seem to be psychogenic. We think that biochemical abnormalities in the basal ganglia are responsible for the dyskinesias and submit data suggesting a reduction of dopamine turnover in the central nervous system of one patient. Both patients have evidence of autoimmune diseases, and one patient's dystonic movements responded to immunosuppressive therapy, suggesting that autoimmune processes contribute to the pathogenic mechanism of Meige's syndrome in some instances.

Entities:  

Mesh:

Year:  1980        PMID: 7384844     DOI: 10.1097/00007611-198007000-00009

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  4 in total

Review 1.  Mutational and biochemical analysis of dopamine in dystonia: evidence for decreased dopamine D2 receptor inhibition.

Authors:  R D Todd; J S Perlmutter
Journal:  Mol Neurobiol       Date:  1998-04       Impact factor: 5.590

Review 2.  Primary dystonia: molecules and mechanisms.

Authors:  Lauren M Tanabe; Connie E Kim; Noga Alagem; William T Dauer
Journal:  Nat Rev Neurol       Date:  2009-10-13       Impact factor: 42.937

3.  Meige's syndrome associated with spasmodic dysphagia.

Authors:  R Kakigi; H Shibasaki; Y Kuroda; T Shin; T Maeyama; S Oono
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-06       Impact factor: 10.154

4.  Decreased [18F]spiperone binding in putamen in idiopathic focal dystonia.

Authors:  J S Perlmutter; M K Stambuk; J Markham; K J Black; L McGee-Minnich; J Jankovic; S M Moerlein
Journal:  J Neurosci       Date:  1997-01-15       Impact factor: 6.167

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.